DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Pulmonary Arterial Hypertension - Epidemiology Forecast to 2028
US$ 3,250.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Pulmonary Arterial Hypertension Key assessments Patient Segmentation in Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension Risk & Burden Factors driving growth in a specific Pulmonary Arterial Hypertension patient ...
January 2019
50 pages
Vitiligo - Epidemiology Forecast to 2028
US$ 3,250.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Vitiligo Key assessments Patient Segmentation in Vitiligo Vitiligo Risk & Burden Factors driving growth in a specific Vitiligo patient population
January 2019
50 pages
Neuroblastoma (NB)- Epidemiology Forecast to 2028
US$ 3,250.00
... Forecast of Neuroblastoma epidemiology 7MM Coverage Total Incident Cases of Neuroblastoma Incident Cases according to segmentation: Neuroblastoma cases by risk groups (low, intermediate and high risk group) in 7MM Key assessments Patient Segmentation Disease Risk ...
January 2019
50 pages
Lipodystrophy Syndrome (LS)- Market Insights, Epidemiology and Market Forecast-2028
US$ 6,250.00
... Key Strengths 10 Years Forecast 7MM Coverage Epidemiology Segmentation Key Cross Competition Highly Analyzed Market Drugs Uptake Lipodystrophy Syndrome (LS) Report Assessment Current Treatment Practices Unmet Needs Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers Key ...
January 2019
100 pages
Lyme disease (LD)- Market Insights, Epidemiology and Market Forecast-2028
US$ 6,250.00
... Key Strengths 10 Years Forecast 7MM Coverage Epidemiology Segmentation Key Cross Competition Highly Analyzed Market Drugs Uptake Lyme disease (LD) Report Assessment Current Treatment Practices Unmet Needs Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers Key ...
January 2019
163 pages
Mycosis Fungoides (MF) - Market Insights, Epidemiology and Market Forecast-2028
US$ 6,250.00
... Fungoides Pipeline Analysis Mycosis Fungoides Market Size and Trends Mycosis Fungoides Market Opportunities Impact of upcoming Therapies in Mycosis Fungoides Mycosis Fungoides Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
October 2018
136 pages
Pulmonary Arterial Hypertension (PAH) - Epidemiology Forecast to 2027
US$ 3,250.00
... 10 Year Forecast of Pulmonary Arterial Hypertension epidemiology 7MM Coverage Total Prevalent Cases of PAH Prevalent Cases according to segmentation: Sub-type specific & Gender- specific prevalence Diagnosed cases of PAH KEY ASSESSMENTS Patient Segmentation Disease Risk & Burden Risk of disease ...
October 2018
56 pages
Acute Renal Failure (ARF)- Epidemiology Forecast to 2027
US$ 3,250.00
... opinion leaders. Acute Renal Failure Epidemiology Segmentation The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [incidence population of ARF, Sex-Specific Incident Hospitalization cases and Stage-wise Incidence of Acute Renal Failure] scenario ...
October 2018
60 pages
ADA-SCID - Competitive Landscape and Market Insight, 2018
US$ 4,750.00
... can be delivered to the clients within 24 hours 'ADA-SCID - Competitive Landscape and Market Insight, 2018', report provides comprehensive Insight about ... to available databases. SCOPE The report provides competitive pipeline landscape of ADA-SCID The report provides the marketed drugs information including ...
October 2018
50 pages
Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2018
US$ 7,500.00
... within 48 hours 'Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2018', report provides comprehensive insights about marketed and pipeline drugs ... databases. SCOPE The report provides competitive pipeline landscape of Epilepsy The report provides the marketed drugs information including its sales ...
October 2018
147 pages
Metachromatic Leukodystrophy - Competitive Landscape and Market Insights, 2018
US$ 5,500.00
... be delivered to the clients within 48 hours 'Metachromatic Leukodystrophy - Competitive Landscape and Market Insights, 2018', report provides comprehensive ... available databases. SCOPE The report provides competitive pipeline landscape of Metachromatic Leukodystrophy The report provides the insight of current ...
October 2018
58 pages
PARP INHIBITORS - COMPETITIVE LANDSCAPE, PIPELINE AND MARKET ANALYSIS, 2018
US$ 3,000.00
... can be delivered to the clients within 48 hours 'PARP Inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2018', report provides comprehensive ... to available databases. SCOPE The report provides competitive pipeline landscape of PARP Inhibitors The report provides the marketed drugs information ...
October 2018
159 pages
Retinal Degeneration - Pipeline Insight, 2018
US$ 1,500.00
... Retinal Degeneration- Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Retinal Degeneration. A detailed picture of the pipeline ... ) Overview of pipeline development activities for Retinal Degeneration Pipeline analysis of therapeutic ...
October 2018
217 pages
WAS - Competitive Landscape and Market Insight, 2018
US$ 4,750.00
... can be delivered to the clients within 24 hours 'Wiskott Aldrich syndrome - Competitive Landscape and Market Insight, 2018', report provides comprehensive Insight about ... Insight to formulate effective R&D development strategies Gaining a full picture of the Competitive Landscape for Evidence based Decisions
October 2018
54 pages
Wet AMD- Pipeline Insight, 2018
US$ 1,500.00
... 'Wet AMD- Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Wet AMD. A detailed picture of the pipeline ... Dormant and Discontinued) Overview of pipeline development activities for Wet AMD Pipeline analysis of therapeutic drugs include ...
October 2018
106 pages
Cinryze - Drug Insights, 2018
US$ 1,000.00
... the historical and forecasted sales of Cinryze till 2022. The report also throws light on Cinryze`s market competition and emerging therapies in the same space as Cinryze. A SWOT analysis of the drug is also ...
October 2018
34 pages
Eosinophilic esophagitis (EoE) - Epidemiology Forecast to 2027
US$ 3,250.00
... patient population The report provides the segmentation of the disease epidemiology by type i.e., Sex-Specific, Age-Specific Prevalence and Prevalence by Clinical Manifestation) in 7MM KEY STRENGTHS 10 Year Forecast of Eosinophilic esophagitis (EoE ...
October 2018
57 pages
Hepatocellular Carcinoma - Market Insights, Epidemiology and Market Forecast-2027
US$ 6,250.00
... Forecast G8 Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Hepatocellular Carcinoma Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
October 2018
201 pages
Hepatocellular Carcinoma (HCC) - Epidemiology Forecast to 2027
US$ 3,250.00
... Forecast of Hepatocellular Carcinoma epidemiology G8 Coverage Total Incident Cases of HCC Incident Cases according to segmentation: Patients by line of therapies (first line and second line of therapies) Diagnosed cases of HCC KEY ASSESSMENTS Patient Segmentation Disease Risk ...
October 2018
92 pages
Niemann-Pick Disease Type C (NPC) - Epidemiology Forecast to 2027
US$ 3,250.00
... of the disease epidemiology by total prevalent patient population, diagnosed population, sub-types and clinical distribution in 7MM KEY STRENGTHS 10 Year Forecast of Niemann-Pick Disease Type C (NPC) epidemiology 7MM Coverage Total Prevalent Cases of Niemann-Pick Disease Type C (NPC) Prevalent Cases according ...
October 2018
76 pages
Primary Hyperoxaluria (PH) - Epidemiology Forecast to 2027
US$ 3,250.00
... Forecast of Primary Hyperoxaluria (PH) 7MM Coverage Total Prevalent Cases of PH Prevalent Cases according to segmentation: Type specific diagnosed prevalent cases and Age-Specific diagnosed prevalent cases KEY ASSESSMENTS Patient Segmentation Disease Risk & Burden Risk of disease ...
October 2018
73 pages
Primary Hyperoxaluria (PH) - Market Insights, Epidemiology and Market Forecast-2027
US$ 6,250.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Primary Hyperoxaluria (PH) Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
October 2018
117 pages
Transthyretin Amyloidosis (ATTR) - Epidemiology Forecast to 2027
US$ 3,250.00
... 10 Year Forecast of Transthyretin Amyloidosis epidemiology 7MM Coverage Total Prevalent Cases of ATTR Prevalent Cases according to segmentation: Type prevalence i.e., Hereditary & Non-hereditary ATTR Diagnosed cases of ATTR KEY ASSESSMENTS Patient Segmentation Disease Risk & Burden Risk of disease by the ...
October 2018
Tuberous Sclerosis Complex (TSC) - Epidemiology Forecast to 2027
US$ 3,250.00
... Forecast of Tuberous Sclerosis Complex (TSC) 7MM Coverage Total Prevalent Cases of TSC Prevalent Cases according to segmentation: De novo mutations and Familiar Cases KEY ASSESSMENTS Patient Segmentation Disease Risk & Burden Risk of disease by the segmentation Factors ...
October 2018
69 pages
